Moore AC - Search Results

1

Effective induction of high-titer antibodies by viral vector vaccines.

Draper SJ, Moore AC, Goodman AL, Long CA, Holder AA, Gilbert SC, Hill F, Hill AV. Draper SJ, et al. Among authors: moore ac. Nat Med. 2008 Aug;14(8):819-21. doi: 10.1038/nm.1850. Epub 2008 Jul 27. Nat Med. 2008. PMID: 18660818 Free PMC article.

2

Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A.

Sridhar S, Reyes-Sandoval A, Draper SJ, Moore AC, Gilbert SC, Gao GP, Wilson JM, Hill AV. Sridhar S, et al. Among authors: moore ac. J Virol. 2008 Apr;82(8):3822-33. doi: 10.1128/JVI.02568-07. Epub 2008 Feb 6. J Virol. 2008. PMID: 18256155 Free PMC article.

3

Progress in DNA-based heterologous prime-boost immunization strategies for malaria.

Moore AC, Hill AV. Moore AC, et al. Immunol Rev. 2004 Jun;199:126-43. doi: 10.1111/j.0105-2896.2004.00138.x. Immunol Rev. 2004. PMID: 15233731 Review.

4

Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.

Hutchings CL, Birkett AJ, Moore AC, Hill AV. Hutchings CL, et al. Among authors: moore ac. Infect Immun. 2007 Dec;75(12):5819-26. doi: 10.1128/IAI.00828-07. Epub 2007 Oct 1. Infect Immun. 2007. PMID: 17908809 Free PMC article.

5

Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.

Draper SJ, Goodman AL, Biswas S, Forbes EK, Moore AC, Gilbert SC, Hill AV. Draper SJ, et al. Among authors: moore ac. Cell Host Microbe. 2009 Jan 22;5(1):95-105. doi: 10.1016/j.chom.2008.12.004. Cell Host Microbe. 2009. PMID: 19154991 Free PMC article.

6

Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.

Webster DP, Dunachie S, McConkey S, Poulton I, Moore AC, Walther M, Laidlaw SM, Peto T, Skinner MA, Gilbert SC, Hill AV. Webster DP, et al. Among authors: moore ac. Vaccine. 2006 Apr 5;24(15):3026-34. doi: 10.1016/j.vaccine.2005.10.058. Epub 2006 Feb 2. Vaccine. 2006. PMID: 16488059 Clinical Trial.

7

Splenic dendritic cell subsets prime and boost CD8 T cells and are involved in the generation of effector CD8 T cells.

Behboudi S, Moore A, Hill AV. Behboudi S, et al. Cell Immunol. 2004 Mar;228(1):15-9. doi: 10.1016/j.cellimm.2004.03.010. Cell Immunol. 2004. PMID: 15203315

8

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.

Behboudi S, Moore A, Gilbert SC, Nicoll CL, Hill AV. Behboudi S, et al. Vaccine. 2004 Oct 22;22(31-32):4326-31. doi: 10.1016/j.vaccine.2004.04.029. Vaccine. 2004. PMID: 15474725

9

A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.

Prieur E, Gilbert SC, Schneider J, Moore AC, Sheu EG, Goonetilleke N, Robson KJ, Hill AV. Prieur E, et al. Among authors: moore ac. Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):290-5. doi: 10.1073/pnas.0307158101. Epub 2003 Dec 23. Proc Natl Acad Sci U S A. 2004. PMID: 14694197 Free PMC article.

10

Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity.

Hutchings CL, Gilbert SC, Hill AV, Moore AC. Hutchings CL, et al. Among authors: moore ac. J Immunol. 2005 Jul 1;175(1):599-606. doi: 10.4049/jimmunol.175.1.599. J Immunol. 2005. PMID: 15972697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters